Alphanet Inc is located in Coral Gables, FL. The organization was established in 1998. According to its NTEE Classification (E99) the organization is classified as: Health Care N.E.C., under the broad grouping of Health Care and related organizations. As of 06/2022, Alphanet Inc employed 43 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Alphanet Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2022, Alphanet Inc generated $15.1m in total revenue. The organization has seen a slow decline revenue. Over the past 3 years, revenues have fallen by an average of (1.9%) each year. All expenses for the organization totaled $12.2m during the year ending 06/2022. As we would expect to see with falling revenues, expenses have declined by (6.7%) per year over the past 3 years. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
ALPHANET PROVIDES HEALTH MANAGEMENT SERVICES TO THOSE DIAGNOSED WITH ALPHA1 ANTITRYPSIN DEFICIENCY AND CONTRIBUTES TO ALPHA1 RESEARCH
Describe the Organization's Program Activity:
Part 3 - Line 4a
ALPHANET SERVICES: ALPHANET IS AN INNOVATIVE 501(C)(3) HEALTH MANAGEMENT COMPANY DEDICATED TO IMPROVING THE LIVES OF PERSONS WITH ALPHA-1 ANTITRYPSIN DEFICIENCY ("ALPHA-1"). ALPHANET EMPLOYS 36 INDIVIDUALS WITH ALPHA-1 TO PROVIDE INFUSION AND HEALTH MANAGEMENT SERVICES TO OVER 7,000 OTHER ALPHAS. ALPHANET SPONSORS AND CONDUCTS ALPHA-1 RELATED CLINICAL TRIALS, PROVIDES ACCREDITED NURSING EDUCATION PROGRAMS AND, THROUGH ITS MEDICAL TEAM, PUBLISHES THE MOST COMPREHENSIVE GUIDE AVAILABLE FOR LIVING WITH ALPHA-1.
ALPHA-1 FOUNDATION: ALPHANET PROVIDES GRANTS TO ALPHA-1 FOUNDATION, A 501(C)(3) ORGANIZATION, TO SUPPORT DETECTION OF ALPHA-1 AFFECTED PERSONS, RESEARCH FOR IMPROVED THERAPIES AND A CURE FOR ALPHA-1 ANTITRYPSIN DEFICIENCY.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Mark B Delvaux President And CEO | OfficerTrustee | 30 | $0 |
Robert A Sandhaus Medical Dir And Evp | OfficerTrustee | 30 | $0 |
Patrick M Lunn Director Of Finance | 30 | $0 | |
Christine L Yllanes Communications Dir | 30 | $0 | |
Victoria E Vaccaro Director Of Hr | 30 | $0 | |
Robert L Greene Jr Chairman | OfficerTrustee | 4 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $1,120,000 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $1,120,000 |
Total Program Service Revenue | $12,201,096 |
Investment income | $460,657 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $148,107 |
Net Gain/Loss on Asset Sales | $1,218,751 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $15,148,611 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $6,950,250 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $248,721 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $1,847,115 |
Pension plan accruals and contributions | $56,922 |
Other employee benefits | $487,302 |
Payroll taxes | $140,651 |
Fees for services: Management | $40,000 |
Fees for services: Legal | $39,728 |
Fees for services: Accounting | $39,296 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $159,495 |
Fees for services: Other | $205,137 |
Advertising and promotion | $53,512 |
Office expenses | $163,079 |
Information technology | $608,501 |
Royalties | $0 |
Occupancy | $18,631 |
Travel | $30,071 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $71,995 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $447,135 |
Insurance | $128,699 |
All other expenses | $0 |
Total functional expenses | $12,157,362 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $1,311,351 |
Savings and temporary cash investments | $3,254,222 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $2,110,048 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $307,219 |
Net Land, buildings, and equipment | $9,460,983 |
Investments—publicly traded securities | $22,557,182 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $39,001,005 |
Accounts payable and accrued expenses | $261,435 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $261,435 |
Net assets without donor restrictions | $38,179,570 |
Net assets with donor restrictions | $560,000 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $39,001,005 |
Over the last fiscal year, Alphanet Inc has awarded $6,950,000 in support to 2 organizations.
Grant Recipient | Amount |
---|---|
ALPHA-1 FOUNDATION INC PURPOSE: Unrestricted | $2,750,000 |
DISEASE MANAGEMENT NETWORK PURPOSE: Unrestricted | $4,200,000 |